enGene Therapeutics Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
Canada (Federal Level)
Country
Quebec, Canada
Business Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, ,
Mailing Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, ,
Phone
(514) 332-4888
Fiscal Year End
1031
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 9, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| 10-Q Quarterly financial report | March 9, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 9, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | February 19, 2026 | View on SEC |
| 10-K/A Annual report amendment | February 19, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
Annual Reports
10-K
December 22, 2025
- The company transitioned its CEO in February 2024, signaling potential new strategic directions.
- enGene completed private placements in February and October 2024 and announced a public offering for November 2025.
Related Companies
Companies in the same industry (SIC: 2836)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX
Biological Products, (No Diagnostic Substances)
Hemab Therapeutics Holdings, Inc.
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
MESOBLAST LTD
MESO
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.